CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to establish a consortium focused on repairing tissue damage in the neuromuscular system using carbon nanotube-based implants. The initial phase involves assessing the biocompatibility of carbon nanoparticles with nervous system tissues to facilitate future developments in tissue repair.
The partners wish to build a long-term European, industry-academia consortium, to work on the problem of repairing tissue damage in the neuromuscular system (NS).
We initially seek to determine the biocompatibility of carbon nanoparticles with tissues of the NS as an essential prelude to our medium to long-term goal of developing marketable novel carbon nanotube-based implants for tissue repair of the NS.
Presently, there is no satisfactory method for repairing extensive damage of the different…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Pharmidex Pharmaceutical Services Limited
United Kingdom, London
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Poland, Krakow
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
